International Equal Pay Day, celebrated on 18 September, represents the longstanding efforts towards the achievement of equal pay for work of equal value. It further builds on the United Nations ...

When you have stage 1 breast cancer, your emotions may span the spectrum from fear and worry to confusion and panic. It's important to have an outlet for your feelings and to remember that it's OK ...

Day 1 is when the body mounts an aggressive immune defense. It does so by releasing proteins called antibodies that coordinate the immune attack and trigger inflammation. Inflammation helps neutralize ...

Last week, controversy over the claims over the prowess of eye drops prescribed for presbyopia (progressive loss of the near focusing ability of the eye due to ageing), led to the Central Drugs ...

Here’s a breakdown of the disputed claims: Company response: There are currently no other eye drops approved for the treatment of presbyopia in India. DCGI response: “…you are informed that the ...

The Drug Controller General of India (DCGI) has suspended the license for PresVu, an eye drop by Entod Pharmaceuticals meant to reduce the need for reading glasses in people with Presbyopia.

PresVu eye drops, developed by Entod Pharmaceuticals, were launched with considerable media attention earlier this month as a novel solution for presbyopia ... ingredient, 1.25% Pilocarpine ...

Since 1967, the annual celebrations of International Literacy Day (ILD) have taken place on 8 September around the world to remind policy-makers, practitioners, and the public of the critical ...

"In this regard, you are informed that the Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25 pc w/v is approved for the treatment of Presbyopia in adults and is not approved for such claim that ...

Presbyopia is an age-related condition in which the eyes gradually lose the ability to focus on nearby objects. Hence, statement 1 is correct. — People usually start to develop presbyopia at around ...

Marketed as a potential breakthrough for presbyopia — a common age-related ... approval was based on a 30-day trial, leaving many questions about its reliability for long-term use.

The United States Food and Drug Administration approved a pilocarpine eye drop for presbyopia in 2021. In India, the government decides on the ceiling price of pilocarpine in 4% and 2% concentrations.